Publication | Closed Access

The ameliorating effect of rosiglitazone on experimental nonalcoholic steatohepatitis is associated with regulating adiponectin receptor expression in rats

Metabolic SyndromeHepatologyBiochemistryMedicinePhysiologyAdiponectin Receptor ExpressionVascular BiologyHepatotoxicityLiver DiseaseExperimental Nonalcoholic SteatohepatitisFatty Liver DiseasePharmacologyDrug-induced Liver InjuryHealth Sciences